UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Number of items: 324.

Article

Al-Azraqi, A; Angus, B; Gokul, S; Sinha, D; Calvert, AH; Lunec, J; (1999) Bcl-2 expression is a potential prognostic co-factor with P53-mutation status in epithelial ovarian carcinoma. BRIT J CANCER , 80 73 - 73.

Anthony, A; Dhillon, AP; Pounder, RE; Wakefield, AJ; (1999) The colon mesenteric margin is most susceptible to injury in an experimental model of colonic ulceration. ALIMENT PHARM THER , 13 (4) 531 - 535.

Anthony, A; Sim, R; Dhillon, AP; Guillaume, JL; Strosberg, AD; Pounder, RE; Wakefield, AJ; (1999) Beta(3)-adrenoceptors co-localise with somatostatin-positive D-cells in human pancreatic islets and duodenal neuroendocrine cells. GUT , 44 A48 - A48.

Anthony, A; Sim, R; Dhillon, AP; Pounder, RE; Wakefield, AJ; (1999) Granulomatous vasculitis in Crohn's disease: An association with the extramural mesenteric vasculature. GUT , 44 A43 - A43.

Ardeshna, KM; Addison, IE; Pizzey, AR; Linch, DC; Devereux, S; Khwaja, A; (1999) P38 stress-activated protein kinase activity is required for the lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. BRIT J HAEMATOL , 105 33 - 33.

Ardeshna, KM; Linch, DC; Devereux, S; Khwaja, A; (1999) p38 stress-activated protein kinase and NF-kappa B activity are required for lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. BLOOD , 94 (10) 214A - 214A.

Ardeshna, KM; Pizzey, AR; Thomas, NSB; Linch, DC; Devereux, S; (1999) Proliferative capacity and susceptibility to retroviral transduction of CD34 and monocyte derived dendritic cells. BRIT J HAEMATOL , 105 29 - 29.

Bagdi, E; Diss, TC; Munson, P; Isaacson, PG; (1999) Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood , 94 (1) 260 - 264.

Barnouin, K; Fredersdorf, S; Eddaoudi, A; Lu, X; Pan, LX; Du, MQ; Mittnacht, S; (1999) Antiproliferative function of p27(kip1) is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene , 18 (46) 6388 - 6397.

Barnouin, K; Fredersdorf, S; Eddaoudi, A; Mittnacht, S; Pan, LX; Du, MQ; Lu, X; (1999) Antiproliferative function of p27(kip1) is frequently inhibited in highly malignant Burkitt's lymphoma cells. ONCOGENE , 18 (46) 6388 - 6397.

Bateman, A; Murphy, S; Emiliusen, L; Ruchatz, A; Melcher, A; Fielding, A; ... Vile, RG; + view all (1999) Fusogenic membrane glycoproteins - A novel class of cytotoxic genes with immunostimulatory properties. GENE THERAPY , 6 S6 - S6.

Bates, AW; (1999) Ethics of human reproductive cloning. J ROY SOC MED , 92 (3) 157 - 158.

Bates, AW; Dodd, SM; (1999) Anomalies in cephalothoracopagus synotus twins and their implications for morphogenesis in conjoined twins. PEDIATR DEVEL PATHOL , 2 (5) 464 - 472.

Bates, AW; Feakins, RM; Scheimberg, I; (1999) Congenital gastro-intestinal stromal tumour: a comparison with similar tumours in adult subjects. J PATHOL , 187 19A - 19A.

Bates, AW; Norton, A; Baithun, SI; (1999) Clinical and pathological features of primary and secondary lymphomas of the urinary bladder. J PATHOL , 187 35A - 35A.

Batey, MA; Wright, JG; Simmonds, D; Proctor, M; Chapman, F; Fishwick, K; ... Boddy, AV; + view all (1999) Population pharmacokinetics of CMF in the adjuvant treatment of breast cancer. BRIT J CANCER , 80 93 - 93.

Bay, JO; Uhrhammer, N; Pernin, D; Presneau, N; Tchirkov, A; Vuillaume, M; ... Bignon, YJ; + view all (1999) High incidence of cancer in a family segregating a mutation of the ATM gene: Possible role of ATM heterozygosity in cancer. HUM MUTAT , 14 (6) 485 - 492.

Beck, S; Geraghty, D; Inoko, H; Rowen, L; Aguado, B; Bahram, S; ... MHC Sequencing Consortium,; + view all (1999) Complete sequence and gene map of a human major histocompatibility complex. NATURE , 401 (6756) 921 - 923.

Beck, S; Olek, A; Walter, J; (1999) From genomics to epigenomics: a loftier view of life. NAT BIOTECHNOL , 17 (12) 1144 - 1144.

Beck, S; Trowsdale, J; (1999) Sequence organisation of the class II region of the human MHC. IMMUNOL REV , 167 201 - 210.

Bentzen, SM; Saunders, MI; Dische, S; (1999) Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology , 53 219 - 226.

Berkenstadt, H; Rosenthal, T; Segal, E; Peleg, E; Ben-Ari, G; Perel, A; Hackshaw, A; (1999) Elevated plasma atrial natriuretic peptide levels after occlusion of the thoracic aorta. Chest , 115 (1) 130 - 134.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; ... P, I; + view all (1999) Nomenclature for factors of the HLA system, 1998. Human Immunology , 60 361 - 395.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; ... P, I; + view all (1999) Nomenclature for factors of the HLA system, 1998. European Journal of Immunogenetics , 26 81 - 116.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; ... P, I; + view all (1999) Nomenclature for factors of the HLA system, 1998. Vox Sanguinis , 77 164 - 191.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; ... P, I; + view all (1999) Nomenclature for factors of the HLA system, 1998. Tissue Antigens , 53 407 - 446.

Borthwick, NJ; Wickremasinghe, RG; Lewin, J; Fairbanks, LD; Bofill, M; (1999) Activation-associated necrosis in human immunodeficiency virus infection. J INFECT DIS , 179 (2) 352 - 360.

Boxer, G; Stuart-Smith, S; Flynn, A; Green, A; Begent, R; (1999) Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome. Br J Cancer , 80 (5-6) 922 - 926. 10.1038/sj.bjc.6690443.

Bramwell, VHC; Steward, WP; Nooij, M; Whelan, J; Craft, AW; Grimer, RJ; ... VanGlabbeke, MM; + view all (1999) Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study. Journal Of Clinical Oncology , 17 3260 - 3269.

Bridgewater, JA; Nelstrop, AE; Rustin, GJ; Gore, ME; McGuire, WP; Hoskins, WJ; (1999) Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel. J Clin Oncol , 17 (2) 501 - 508.

Brimmell, M; Burns, JS; Munson, P; McDonald, L; O'Hare, MJ; Lakhani, SR; Packham, G; (1999) High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. BRIT J CANCER , 81 (6) 1042 - 1051.

Brock, CS; Davies, C; Ledermann, JA; Stein, RC; (1999) A pilot study of infusional chemotherapy FMM (5-fluorouracil, mitoxantrone, methotrexate) in advanced breast cancer. British Journal of Cancer , 80 298 - 298.

Brock, CS; Davies, C; Ledermann, JA; Stein, RC; (1999) A pilot study of infusional chemotherapy FMM (5-fluorouracil, mitoxantrone, methotrexate) in advanced breast cancer. BRIT J CANCER , 80 103 - 103.

Brooks, N; McHugh, PJ; Lee, M; Hartley, JA; (1999) The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size. ANTI-CANCER DRUG DES , 14 (1) 11 - 18.

Buckley, CD; Pilling, D; Henriquez, NV; Parsonage, G; Threlfall, K; Scheel-Toellner, D; ... Salmon, M; + view all (1999) RGD peptides induce apoptosis by direct caspase-3 activation. 534 - 539.

Byrne, E; (1999) Medicine at the beginning of the 21st century: a personal viewpoint - a peripatetic overview. Australian and New Zealand Journal of Medicine , 29 (6) 819 - 821.

Byrne, E; (1999) New advances in myopathies : overview from the IX International Congress on Neuromuscular Disease. Proceedings of the Royal College of Physicians of Edinburgh , 29 (4) 280 - 283.

Calvert, AH; Ghokul, S; Al-Azraqi, A; Wright, J; Lind, M; Bailey, N; ... Fenwick, J; + view all (1999) Carboplatin and paclitaxel, alone and in combination: Dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene. SEMINARS IN ONCOLOGY , 26 (1) 90 - 94.

Calvert, H; (1999) An overview of folate metabolism: Features relevant to the action and toxicities of antifolate anticancer agents. SEMINARS IN ONCOLOGY , 26 (2) 3 - 10.

Calvert, H; (1999) MTA, a novel multitargeted antifolate, from preclinical to phase I and beyond: summary and conclusions. Semin Oncol , 26 (2 Suppl 6) 105 - 108.

Calvert, H; (1999) MTA: Summary and conclusions. SEMIN ONCOL , 26 (2) 105 - 108.

Calvert, PM; Highley, MS; Hughes, AN; Plummer, ER; Azzabi, AST; Verrill, MW; ... Calvert, AH; + view all (1999) A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors. CLIN CANCER RES , 5 3796S - 3796S.

Cannell, E; Mittnacht, S; (1999) Viral encoded cyclins. Semin Cancer Biol , 9 (3) 221 - 229. 10.1006/scbi.1999.0090.

Caplin, ME; Clarke, P; Grimes, S; Dhillon, AP; Khan, K; Savage, K; ... Watson, SA; + view all (1999) Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy. REGUL PEPTIDES , 84 (1-3) 81 - 89.

Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ; (1999) Increased levels of activated factor XII (FXIIa) in hyperlipidaemia. THROMB HAEMOSTASIS 729 - 729.

Casey, JL; Pedley, RB; King, DJ; Boden, R; Chapman, AP; Yarranton, GT; Begent, RHJ; (1999) Improved tumour targeting of di-Fab ' fragments modified with polyethylene glycol. TUMOR TARGET , 4 (4) 235 - 244.

Casey, JL; Pedley, RB; King, DJ; Green, AJ; Yarranton, GT; Begent, RH; (1999) Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments. Br J Cancer , 81 (6) 972 - 980. 10.1038/sj.bjc.6690795.

Casey, JL; Pedley, RB; King, DJ; Green, AJ; Yarranton, GT; Begent, RHJ; (1999) Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments. BRIT J CANCER , 81 (6) 972 - 980.

Chakraverty, RK; Hickson, ID; (1999) Defending genome integrity during DNA replication: a proposed role for RecQ family helicases. Bioessays , 21 (4) 286 - 294. 10.1002/(SICI)1521-1878(199904)21:4<286::AID-BIES4>3.0.CO;2-Z.

Collins, S; McKelvie, P; Dennett, X; Byrne, E; (1999) Idiopathic granulomatous myositis: does the clinical spectrum include polymyalgia rheumatica? Journal of Clinical Neuroscience , 6 (3) 255 - 259.

Cooke, SP; Pedley, RB; Boden, R; Holliger, P; Winter, G; Begent, RHJ; Chester, KA; (1999) Tumour targeting using MFE-23 :: TNF alpha fusion protein. BRIT J CANCER , 80 85 - 85.

Crawford, J; Ianzano, L; Savino, M; Whitmore, S; Cleton-Jansen, AM; Settasatian, C; ... Savoia, A; + view all (1999) The PISSLRE gene: Structure, exon skipping, and exclusion as tumor suppressor in breast cancer. GENOMICS , 56 (1) 90 - 97.

Crawley, CR; Hinchliffe, SJ; Reid, ED; Lomas, DA; (1999) Early supported discharge as an alternative to long stay hospital admission in exacerbations of chronic obstructive pulmonary disease. THORAX , 54 A44 - A44.

Cullen, M; Hancock, BW; Gregory, WM; Hudson, GV; Burton, A; Selby, P; ... Linch, DC; + view all (1999) Ch1VPP/PABIOE is superior to PABIOE: Interim results of the British national lymphoma investigation/central lymphoma group randomised trial in advanced Hodgkin's disease. BRIT J CANCER , 80 18 - 18.

Curtin, NJ; Bowman, KJ; Turner, RN; Huang, B; Loughlin, PJ; Calvert, AH; ... Newell, DR; + view all (1999) Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha(1)-acid glycoprotein binding. BRIT J CANCER , 80 (11) 1738 - 1746.

Curtin, NJ; Kyle, S; Wang, LZ; Durkacz, BW; White, AJ; Srinivasan, S; ... Hostomsky, Z; + view all (1999) Potentiation of temozolomide and topotecan growth inhibition by novel potent benzimidazole poly(ADP-ribose) polymerase (PARP) inhibitors. CLIN CANCER RES , 5 3834S - 3834S.

D'Sa, S; Verfuerth, S; Vyas, P; Langabeer, S; Perry, A; Peniket, A; Mackinnon, S; (1999) Early PCR-negativity after allogeneic BMT in adults with t(4;11) ALL in the absence of acute or chronic GVHD. BONE MARROW TRANSPL , 23 (7) 695 - 696.

Dafforn, TR; Mahadeva, R; Elliott, PR; Sivasothy, P; Lomas, DA; (1999) A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem , 274 (14) 9548 - 9555. Gold open access

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Wales, JKH; ... Robinson, ICAF; + view all (1999) HESX1: a novel gene implicated in a familial form of septo-optic dysplasia. ACTA PAEDIATRICA , 88 49 - 54.

Davis, RL; Shrimpton, AE; Holohan, PD; Bradshaw, C; Feiglin, D; Collins, GH; ... Lomas, DA; + view all (1999) Familial dementia caused by polymerization of mutant neuroserpin. Nature , 401 (6751) 376 - 379. 10.1038/43894.

Davis, RL; Shrimpton, AE; Holohan, PD; Bradshaw, C; Feiglin, D; Collins, GH; ... Lomas, DA; + view all (1999) Familial dementia caused by polymlerization of mutant neurosergin. NATURE , 401 (6751) 376 - 379. 10.1038/43897.

De Silva, IU; Clingen, PH; McHugh, PJ; Tilby, MJ; Gregson, SJ; Howard, P; ... Hartley, JA; + view all (1999) The role of nucleotide excision repair in the repair of DNA damage induced by mono- and bifunctional, major and minor groove alkylating agents. BRIT J CANCER , 80 42 - 42.

Delaney, CA; Wang, LZ; Kyle, LZ; Srinivasan, S; White, AW; Curtin, NJ; ... Newell, DR; + view all (1999) Potentiation of temozolomide and topotecan cytotoxicity by PARP inhibitors in a panel of human cancer cell lines. BRIT J CANCER , 80 44 - 44.

Delassus, S; Titley, I; Enver, T; (1999) Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. BLOOD , 94 (5) 1495 - 1503.

Devereux, S; Corney, C; Macdonald, C; Watts, M; Ward, M; Bank, A; Linch, DC; (1999) Multi-drug resistance (MDR-1) gene transfer in patients with poor prognosis lymphoma undergoing high dose therapy and CD34 selected peripheral blood stem cell transplantation (PBSCT). BONE MARROW TRANSPL , 23 S85 - S85.

Dische, S; Saunders, MI; Sealy, R; Werner, ID; Verma, N; Foy, C; Bentzen, SM; (1999) Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial. Radiotherapy and Oncology , 53 93 - 98.

Donohoe, S; Geary, M; Kingdom, JCP; Jauniaux, E; Purdy, G; Mackie, IJ; (1999) Maternal cardiolipin, beta(2)-glycoprotein-I and prothrombin antibody expression in high-risk pregnancies with bilateral abnormal uterine artery Doppler waveforms. ULTRASOUND OBST GYN , 13 (5) 317 - 322.

Donohoe, S; Kingdom, J; Mackie, I; Jauniaux, E; Machin, S; (1999) beta(2)GPI and Annexin V in normal and APS villous placenta. BRIT J HAEMATOL , 105 28 - 28.

Donohoe, S; Kingdom, JCP; Mackie, IJ; (1999) Affinity purified human antiphospholipid antibodies bind normal term placenta. LUPUS , 8 (7) 525 - 531.

Donohoe, S; Mackie, I; Kingdom, J; Jauniaux, E; Machin, S; (1999) Placental expression of beta(2)GPI and annexin V in normal and APS pregnancies. THROMB HAEMOSTASIS 66 - 66.

Dunham, I; Shimizu, N; Roe, BA; Chissoe, S; Dunham, I; Hunt, AR; ... O'Brien, KP; + view all (1999) The DNA sequence of human chromosome 22. NATURE , 402 (6761) 489 - 495.

Duro, D; Schulze, A; Vogt, B; Bartek, J; Mittnacht, S; Jansen-Dürr, P; (1999) Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8. J Gen Virol , 80 ( Pt 3) 549 - 555.

Dutt, N; Bates, AW; Baithun, SI; (1999) Secondary tumours of the testis: a clinico-pathological study of 31 cases. J PATHOL , 189 18A - 18A.

Elliott, PR; Abrahams, JP; Lomas, DA; (1999) Crystal structure of wildtype alpha(1)-antitrypsin. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 159 (3) A192 - A192.

Enver, T; (1999) B-cell commitment: Pax5 is the deciding factor. CURR BIOL , 9 (24) R933 - R935.

Espada, J; Perez-Moreno, M; Braga, VMM; Rodriguez-Viciana, P; Cano, A; (1999) H-ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J CELL BIOL , 146 (5) 967 - 980.

Falzetti, D; Vermeesch, JR; Hood, TL; Nacheva, EP; Matteucci, C; Martelli, MF; ... Mecucci, C; + view all (1999) Identification of multiple copies of a 20q-chromosome in a case of myelodysplastic syndrome: a FISH study. LEUKEMIA RES , 23 (4) 407 - 413.

Fielding, A; Bateman, A; Vile, R; Cosset, FL; Russell, S; (1999) Targeting the cytotoxicity of a fusogenic gibbon ape leukaemia virus envelope glycoprotein by ligand display. GENE THERAPY , 6 S8 - S8.

Fierabracci, A; Hammond, L; Lowdell, M; Chiovato, L; Goode, AW; Bottazzo, GF; Mirakian, R; (1999) The effect of staphylococcal enterotoxin B on thyrocyte HLA molecule expression. J Autoimmun , 12 (4) 305 - 314. 10.1006/jaut.1999.0279.

Flynn, AA; Green, AJ; Boxer, G; Pedley, RB; Begent, RH; (1999) A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology. Phys Med Biol , 44 (7) N151 - N159.

Flynn, AA; Green, AJ; Boxer, G; Pedley, RB; Begent, RHJ; (1999) A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology. PHYS MED BIOL , 44 (7) N151 - N159.

Flynn, AA; Green, AJ; Boxer, GM; Casey, JL; Pedley, RB; Begent, RHJ; (1999) A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model. INT J RADIAT ONCOL , 43 (1) 183 - 189.

Freeman, AA; Stoeber, K; Morris, LS; Williams, GH; Laskey, RA; Coleman, N; (1999) New biological markers for dysplasia. J PATHOL , 187 22A - 22A.

Gaillard, MC; Mahadeva, R; Lomas, DA; (1999) Identification of DNA polymorphisms associated with the V type alpha1-antitrypsin gene. Biochim Biophys Acta , 1444 (2) 166 - 170.

Gale, RE; (1999) Evaluation of clonality in myeloid stem-cell disorders. SEMIN HEMATOL , 36 (4) 361 - 372.

Gale, RE; Forbes, LV; Pizzey, A; Pouwels, K; Linch, DC; (1999) A leukemia-associated mutation in the G-CSF receptor implies a role for the transmembrane domain in receptor activation. BLOOD , 94 (10) 45A - 45A.

Garcia, SB; Park, HS; Novelli, M; Wright, NA; ',; (1999) Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. The Journal of Pathology , 187 (1) 61 - 81.

Gardiner, C; Harrison, P; Chavda, N; Mackie, IJ; Machin, SJ; (1999) Platelet activation responses in vitro to human mast cell activation. BRIT J HAEMATOL , 106 (1) 208 - 215.

Gardiner, C; Harrison, P; Chavda, N; Mackie, IJ; Machin, SJ; (1999) Platelet aggregation in response to in vitro human mast cell activation. THROMB HAEMOSTASIS 461 - 461.

Gardiner, C; Mackie, IJ; Machin, SJ; Taberner, D; Leeming, D; Malia, RG; ... Greaves, M; + view all (1999) Modification of DRVVT calculation methods improves the specificity of lupus anticoagulants. THROMB HAEMOSTASIS 587 - 587.

Gerhard, DS; Xu, Z; Nguyen, L; Li, Y; Mungall, A; Beck, S; ... Rader, JS; + view all (1999) The generation of a sequence-ready contig encompassing the cervical tumor suppressor gene (TSG) on 6p23. AM J HUM GENET , 65 (4) A127 - A127.

Ghazal-Aswad, S; Tilby, MJ; Lind, M; Baily, N; Sinha, DP; Calvert, AH; Newell, DR; (1999) Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels. ANN ONCOL , 10 (3) 329 - 334.

Goodchild, K; Hoskin, P; Dische, S; Pigott, K; Powell, M; Saunders, M; (1999) A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas. Radiotherapy and Oncology , 50 29 - 31.

Gooding, RP; Bybee, A; Cooke, F; Little, AM; Marsh, SGE; Coelho, E; ... Apperley, JF; + view all (1999) Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia. British Journal of Haematology , 106 669 - 681.

Gooptu, B; Chang, WSW; Lomas, DA; (1999) Alpha(1)-antichymotrypsin deficiency: Conformational transitions in chronic airflow obstruction. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 159 (3) A798 - A798.

Gooptu, B; Hazes, B; Chang, WSW; Dafforn, TR; Read, RJ; Carrell, RW; Lomas, DA; (1999) Protein structural transitions in chronic airflow obstruction: Insights from the characterisation and 2.5 angstrom crystal structure of a pathogenic form of alpha(1)-antichymotrypsin. THORAX , 54 A8 - A8.

Gorodetsky, R; Lotan, C; Piggot, K; Pierce, LJ; Polyansky, I; Dische, S; ... Vexler, A; + view all (1999) Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. International Journal of Radiation Oncology Biology Physics , 45 893 - 900.

Gosriwatana, I; Loreal, O; Lu, S; Brissot, P; Porter, J; Hider, RC; (1999) Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. ANAL BIOCHEM , 273 (2) 212 - 220.

Grassilli, E; Salomoni, P; Perrotti, D; Franceschi, C; Calabretta, B; (1999) Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. CANCER RES , 59 (10) 2451 - 2456.

Gray, E; Mackie, I; Greaves, M; (1999) A strategy for improving the quality of lupus anticoagulant testing: Establishment of the 1st British Reference Plasmas Panel for Lupus Anticoagulant. THROMB HAEMOSTASIS 67 - 67.

Gray, E; Mackie, I; Greaves, M; (1999) Calibration of the 1st British reference plasmas panel for lupus anticoagulants. BRIT J HAEMATOL , 105 97 - 97.

Gribble, S; Andrews, K; Williams, D; Grace, CD; Green, AR; Nacheva, EP; (1999) Two telomeres detected by FISH in the short arm of a marker derived from chromosome 16 in an infant with thrombocytopenia. CYTOGENET CELL GENET , 85 (1-2) 37 - 37.

Gribble, SM; Roberts, I; Grace, C; Green, AR; Nacheva, EP; (1999) M-FISH and CGH analysis of 10 CML derived cell lines; identification of a common region of amplification on the long arm of chromosome 8. CYTOGENET CELL GENET , 85 (1-2) 38 - 38.

Griffin, RJ; Barlow, HC; Curtin, NJ; Calvert, AH; Golding, BT; Newell, DR; Smith, PG; (1999) 2,6-Disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines as nucleoside transport inhibitors: Structure-activity relationships for binding to alpha(1)-acid glycoprotein (AGP). CLIN CANCER RES , 5 3843S - 3843S.

Griffioen, A; Sabin, CA; Devereux, H; Yee, TT; Lee, CA; (1999) Natural history of hepatitis C virus in a cohort of individuals with clotting factor disorders treated with unsterilised clotting concentrates. THROMB HAEMOSTASIS 475 - 476.

Griffioen, A; Sabin, CA; Devereux, H; Yee, TT; Lee, CA; (1999) Natural history of hepatitis C virus in a cohort of individuals with clotting factor disorders treated with unsterilised clotting concentrates. BRIT J HAEMATOL , 105 50 - 50.

Griffiths, DJ; Cooke, SP; Herve, C; Rigby, SP; Mallon, E; Hajeer, A; ... Venables, PJW; + view all (1999) Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. ARTHRITIS RHEUM , 42 (3) 448 - 454.

Grimaldi, KA; Bingham, JP; Hartley, JA; (1999) PCR-based assays for strand-specific measurement of DNA damage and repair. I. Strand-specific quantitative PCR. Methods Mol Biol , 113 227 - 240. 10.1385/1-59259-675-4:227.

Grimaldi, KA; McAdam, SR; Hartley, JA; (1999) PCR-based assays for strand-specific measurement of DNA damage and repair. II. Single-strand ligation-PCR. Methods Mol Biol , 113 241 - 255. 10.1385/1-59259-675-4:241.

Guo, AL; Zhong, S; Ronchetti, S; Ruggero, D; Salomoni, P; Pandolfi, PP; (1999) PML is required for the ability of DAXX to regulate programmed cell death. BLOOD , 94 (10) 489A - 489A.

Hamdulay, SS; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (1999) Differential expression of the alternatively spliced STAT-1 alpha and beta mRNA and its products in B-CLL and tonsillar B-cells. BRIT J HAEMATOL , 105 86 - 86.

Hargreaves, RHJ; O'Hare, CC; Hartley, JA; Ross, D; Butler, J; (1999) Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents. J MED CHEM , 42 (12) 2245 - 2250.

Harrison, CN; Gale, RE; Machin, SJ; Linch, DC; (1999) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. BLOOD , 93 (2) 417 - 424.

Harrison, CN; Gale, RE; Machin, SJ; Linch, DC; Pezella, F; Mire-Sluis, A; (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. British Journal of Haematology , 107 (1) 139 - 147. 10.1046/j.1365-2141.1999.01667.x.

Harrison, CN; Gale, RE; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Essential thrombocythaemia with polyclonal haemopoiesis is not due to disruption in levels of interleukins-6,-11, thrombopoietin, or transforming growth factor beta 1 levels. BLOOD , 94 (10) 112A - 112A.

Harrison, CN; Gale, RE; Pezella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. BRIT J HAEMATOL , 107 (1) 139 - 147.

Harrison, CN; Gregory, W; Hudson, GV; Devereux, S; Goldstone, AH; Hancock, B; ... Linch, DC; + view all (1999) High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. BRIT J CANCER , 81 (3) 476 - 483.

Harrison, P; Robinson, M; Khair, K; Liesner, R; Carr, P; Criddle, S; ... Machin, S; + view all (1999) The PFA-100(R) - A potential screening tool for the assessment of platelet dysfunction. THROMB HAEMOSTASIS 743 - 743.

Harrison, P; Robinson, MSC; Mackie, IJ; Joseph, J; McDonald, SJ; Liesner, R; ... Machin, SJ; + view all (1999) Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis. BLOOD COAGUL FIBRIN , 10 (1) 25 - 31.

Harrison, P; Robinson, MSC; Mackie, IJ; Joseph, J; McDonald, SJ; Machin, SJ; ... Pasi, J; + view all (1999) Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis , 10 (1) 25 - 31.

Hartley, JA; O'Hare, CC; Baumgart, J; (1999) DNA alkylation and interstrand cross-linking by treosulfan. BRIT J CANCER , 79 (2) 264 - 266.

Hartley, JM; Spanswick, VJ; Gander, M; Giacomini, G; Whelan, J; Souhami, RL; Hartley, JA; (1999) Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. CLIN CANCER RES , 5 (3) 507 - 512.

Haynes, AP; Kottiridis, P; Byrne, JL; Goldstone, A; Russell, NH; Linch, DC; McKinnon, S; (1999) Results of allogeneic transplantation for lymphoma - A report on 41 patients. BRIT J HAEMATOL , 105 87 - 87.

Henriquez, NV; Floettmann, E; Salmon, M; Rowe, M; Rickinson, AB; (1999) Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1. 3298 - 3307.

Heppell-Parton, AC; Nacheva, E; Carter, NP; Bergh, J; Ogilvie, D; Rabbitts, PH; (1999) Elucidation of the mechanism of homozygous deletion of 3p12-13 in the U2020 cell line reveals the unexpected involvement of other chromosomes. Cancer Genet Cytogenet , 111 (2) 105 - 110.

Heppell-Parton, AC; Nacheva, E; Carter, NP; Rabbitts, PH; (1999) A combined approach of conventional and molecular cytogenetics for detailed karyotypic analysis of the small cell lung carcinoma cell line U2020. Cancer Genet Cytogenet , 108 (2) 110 - 119.

Heyworth, C; Gale, K; Dexter, M; May, G; Enver, T; (1999) A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal. GENE DEV , 13 (14) 1847 - 1860.

Hillan, KJ; Hagler, KE; MacSween, RNM; Ryan, AM; Renz, ME; Chiu, HH; ... Fong, S; + view all (1999) Expression of the mucosal vascular addressin MAdCAM-1, in inflammatory liver disease. LIVER , 19 (6) 509 - 518.

Hillmen, P; Richards, SJ; Baker, AJ; Gale, RE; Rawstron, AC; Crawford, DH; ... Layton, DM; + view all (1999) Congenital paroxysmal nocturnal haemoglobinuria. BRIT J HAEMATOL , 105 64 - 64.

Hinchliffe, SJ; Reid, ED; Lomas, DA; (1999) Familial risk of airflow obstruction and emphysema. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 159 (3) A809 - A809.

Hochhauser, D; (1999) Cancer researchers get down to arrays at AACR. LANCET , 353 (9162) 1418 - 1418.

Hochhauser, D; Valkov, NI; Gump, JL; Wei, I; O'Hare, C; Hartley, J; ... Sullivan, DM; + view all (1999) Effects of wild-type p53 expression on the quantity and activity of topoisomerase II alpha and beta in various human cancer cell lines. J CELL BIOCHEM , 75 (2) 245 - 257.

Holmes, ZR; Regan, L; Chilcott, I; Cohen, H; (1999) The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. BRIT J HAEMATOL , 105 (1) 98 - 101.

Hoskin, PJ; Abdelath, O; Phillips, H; Gilligan, S; Saunders, MI; Broderick, P; Baddeley, H; (1999) Inspired and expired gas concentrations in man during carbogen breathing. Radiotherapy and Oncology , 51 175 - 177.

Hoskin, PJ; Saunders, MI; Goodchild, K; Powell, MEB; Taylor, NJ; Baddeley, H; (1999) Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. British Journal of Radiology , 72 1093 - 1098.

Hsieh, JK; Chan, FS; O'Connor, DJ; Mittnacht, S; Zhong, S; Lu, X; (1999) RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell , 3 (2) 181 - 193.

Hughes, A; Calvert, H; (1999) An update on thymidylate synthase inhibitors. ANN ONCOL , 10 (10) 1137 - 1139.

Hughes, AN; Rafi, I; Griffin, MJ; Calvert, AH; Newell, DR; Calvete, JA; ... Boddy, AV; + view all (1999) Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days. CLIN CANCER RES , 5 (1) 111 - 118.

Hunalov, A; Robson, L; Perkins, SJ; Begent, RHJ; Chester, KA; (1999) A vector for expression of dimeric and chelating forms of anti-CEA scFvS. BRIT J CANCER , 80 51 - 51.

Huntington, JA; Pannu, NS; Hazes, B; Read, RJ; Lomas, DA; Carrell, RW; (1999) A 2.6 A structure of a serpin polymer and implications for conformational disease. J Mol Biol , 293 (3) 449 - 455. 10.1006/jmbi.1999.3184.

Ings, SJ; Schey, S; Hancock, B; Watts, MJ; Vandenberghe, E; Goldstone, AH; ... Linch, DC; + view all (1999) Results of a BNLI randomized trial of G-CSF dose after cyclophosphamide 1.5g/m(2) for progenitor cell mobilization. BLOOD , 94 (10) 666A - 666A.

Isaacson, PG; Diss, TC; Wotherspoon, AC; Barbazza, R; Boni, M; Doglioni, C; (1999) Long-term follow-up of gastric MALT lymphoma treated by eradication of H pylori with antibodies. Gastroenterology , 117 (3) 750 - 751.

Janitz, K; Wild, A; Beck, S; Savasta, S; Beluffi, G; Ziegler, A; Volz, A; (1999) Genomic organization of the HSET locus and the possible association of HLA-linked genes with immotile cilia syndrome (ICS). IMMUNOGENETICS , 49 (7-8) 644 - 652.

Joiner, MC; Marples, B; Lambin, P; Short, S; Turesson, I; (1999) Low-dose hypersensitivity: current status and possible mechanisms. International Journal of Radiation Oncology Biology Physics , 49 (2) 379 - 389.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (1999) The putative role of Fas and caspase 8 in the killing of B-CLL cells by cytotoxic drugs and radiation. BLOOD , 94 (10) 310A - 310A.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (1999) The putative role of induced Fas expression in the killing of B-CLL cells by DNA damaging agents. BRIT J HAEMATOL , 105 90 - 90.

Jones, DW; Joseph, JE; Donohoe, S; Mackie, IJ; Gallimore, MJ; Winter, M; (1999) Factor XII antibodies in patients with phospholipid antibodies: Are they predictors of thrombotic risk? THROMB HAEMOSTASIS 66 - 67.

Joseph, JE; Harrison, P; Mackie, IJ; Machin, SJ; (1999) Platelet activation and platelet-leukocyte complexes in the primary antiphospholipid syndrome (PAPS) and systemic lupus erythematosus (SLE). THROMB HAEMOSTASIS 68 - 69.

Joseph, JE; Mackie, IJ; Harrison, P; Machin, SJ; (1999) Increased thrombin generation in patients with the primary antiphospholipid syndrome. BRIT J HAEMATOL , 105 44 - 44.

Kaufman, J; Jacob, J; Shaw, I; Walker, B; Milne, S; Beck, S; Salomonsen, J; (1999) Gene organisation determines evolution of function in the chicken MHC. IMMUNOL REV , 167 101 - 117.

Kaufman, J; Milne, S; Gobel, TWF; Walker, BA; Jacob, JP; Auffray, C; ... Beck, S; + view all (1999) The chicken B locus is a minimal essential major histocompatibility complex. NATURE , 401 (6756) 923 - 925.

Keshtgar, MRS; Kocjan, G; Lakhani, SR; Ell, PJ; (1999) Is imprint cytology reliable in sentinel node biopsy for breast cancer? J NUCL MED , 40 (5) 251P - 252P.

Khwaja, A; (1999) Akt is more than just a Bad kinase. Nature , 401 (6748) 33 - 34. 10.1038/43354.

Khwaja, A; (1999) Apoptosis - Akt is more than just a Bad kinase. NATURE , 401 (6748) 33 - 34.

Khwaja, A; Hassan, R; Tatton, EL; Watts, M; Linch, DC; (1999) Inhibition of myeloid cell apoptosis by G-CSF and GM-CSF involves different signal transduction pathways depending on the stage of differentiation. BRIT J HAEMATOL , 105 102 - 102.

Khwaja, A; Tatton, L; (1999) Caspase-mediated proteolysis and activation of protein kinase C delta plays a central role in neutrophil apoptosis. BLOOD , 94 (1) 291 - 301.

Khwaja, A; Tatton, L; (1999) Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J BIOL CHEM , 274 (51) 36817 - 36823. Gold open access

Kiani-Alikhan, S; Chester, KA; Ledermann, JA; Beverley, PCL; (1999) Potentiation of the activity of dendritic cells by DNA. BRIT J CANCER , 80 52 - 52.

Koh, MBC; Lowdell, MW; Prentice, HG; (1999) The GvH reaction: The 'cytokine storm' and its effect on lymphocyte alloreactive responses. BRIT J HAEMATOL , 105 60 - 60.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (1999) Establishment of the NOD/SCID mouse as a model for allogeneic GvHD. BLOOD , 94 (10) 330B - 330B.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (1999) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in a NOD/SCID mouse model. BLOOD , 94 (10) 330B - 330B.

Koh, MBC; Prentice, HG; Lowdell, MW; (1999) Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis. BONE MARROW TRANSPL , 23 (10) 1071 - 1079.

Kottaridis, PD; Chakraverty, R; Milligan, DW; Chakrabarti, S; Robinson, S; Chopra, R; ... Mackinnon, S; + view all (1999) A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. BLOOD , 94 (10) 348A - 348A.

Kottaridis, PD; Ketley, N; Peggs, K; Chakraverty, R; Ralleigh, G; Shaw, P; ... Mackinnon, S; + view all (1999) An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion. BONE MARROW TRANSPL , 24 (7) 807 - 809.

Kottaridis, PD; Rees, H; Smith, G; Garner, SF; Perry, AR; Peniket, AJ; ... Ouwehand, WH; + view all (1999) A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation. BONE MARROW TRANSPL , 23 (7) 739 - 741.

Lader, CS; Scopes, J; Horton, MA; Flanagan, AM; (1999) Human osteoclasts generated with soluble trance - Differences from stromal-cell based culture systems. J BONE MINER RES , 14 (6) 1033 - 1033.

Lam, EWF; Glassford, J; van der Sman, J; Banerji, L; Pizzey, AR; Thomas, NSB; Klaus, GGB; (1999) Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors. EUR J IMMUNOL , 29 (10) 3380 - 3389.

Langabeer, SE; Gale, RE; Mackinnon, S; Linch, DC; (1999) Transcription mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. BLOOD , 94 (10) 283A - 283A.

Langabeer, SE; Grimwade, D; Walker, H; Burnett, AK; Goldstone, AH; Linch, DC; (1999) EV1-1 expression in acute promyelocytic leukaemia. BRIT J HAEMATOL , 105 74 - 74.

Laplace-Marieze, V; Presneau, N; Sylvain, V; Kwiatkowski, F; Lortholary, A; Hardouin, A; Bignon, YJ; (1999) Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families. INT J ONCOL , 14 (5) 971 - 977.

Ledermann, JA; Maughan, TS; James, RD; Kerr, D; McArdle, C; Seymour, M; ... Stephens, RJ; + view all (1999) Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer. British Journal of Cancer , 80 410 - 410.

Ledermann, JA; Maughan, TS; James, RD; Kerr, D; McArdle, C; Seymour, M; ... MRC Colorectal Cancer Working Party,; + view all (1999) Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer. BRIT J CANCER , 80 20 - 20.

Lee, CK; de Miranda, MP; Ledermann, JA; de Elvira, MCR; Nelstrop, AE; Lambert, HE; ... Trask, CWL; + view all (1999) Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy. EUR J CANCER , 35 (5) 727 - 732.

Leevers, SJ; Vanhaesebroeck, B; Waterfield, MD; (1999) Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol , 11 (2) 219 - 225.

Linch, DC; Goldstone, AH; (1999) High-dose therapy for Hodgkin's disease. BRIT J HAEMATOL , 107 (4) 685 - 690.

Lindh, M; Hannoun, C; Dhillon, AP; Norkrans, G; Horal, P; (1999) Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J INFECT DIS , 179 (4) 775 - 782.

Lindh, M; Savage, K; Rees, J; Garwood, L; Horal, P; Norkrans, G; Dhillon, AP; (1999) HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. LIVER , 19 (4) 294 - 298.

Louis, R; Shute, J; Goldring, K; Perks, B; Lau, LCK; Radermecker, M; Djukanovic, R; (1999) The effect of processing on inflammatory markers in induced sputum. EUR RESPIR J , 13 (3) 660 - 667.

Lowdell, MW; Craston, R; Prentice, HG; (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following alpha interferon treatment. BRIT J HAEMATOL , 105 78 - 78.

Lowdell, MW; Craston, R; Prentice, HG; (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment. CYTOKINES CELL MOL T , 5 (2) 119 - 121.

Lowdell, MW; Wood, ME; Corbo, M; Hennessy, B; Cotter, FE; Craston, R; Prentice, HG; (1999) AML-reactive autologous NK cells predict patient survival and can prevent leukaemia outgrowth in an animal model. BLOOD , 94 (10) 596A - 596A.

Lowdell, MW; Wood, ME; Craston, R; Prentice, HG; (1999) Measurement of autologous immunity to leukaemia can predict maintenance of complete remission at two years. BRIT J HAEMATOL , 105 59 - 59.

Mackinnon, S; Kottaridis, P; Perry, A; Chakrabarti, S; Milligan, DW; Pettengell, R; ... Goldstone, AH; + view all (1999) Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation. BRIT J HAEMATOL , 105 31 - 31.

Mahadeva, R; Chang, WS; Dafforn, TR; Oakley, DJ; Foreman, RC; Calvin, J; ... Lomas, DA; + view all (1999) Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest , 103 (7) 999 - 1006. 10.1172/JCI4874.

Mahadeva, R; Dunn, AC; Westerbeek, RC; Sharples, L; Whitehouse, DB; Carroll, NR; ... Lockwood, CM; + view all (1999) Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol , 117 (3) 561 - 567.

Mahadeva, R; Elliott, PR; Dafforn, T; Oakley, DJ; Foreman, RC; Chang, WWS; Lomas, DA; (1999) Polymerisation and deficiency of F alpha(1)-antitrypsin (223Arg -> Cys) is independent of the 223Arg-Glu reactive loop salt bridge. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 159 (3) A810 - A810.

Majewski, M; Nieborowska-Skorska, M; Salomoni, P; Slupianek, A; Reiss, K; Trotta, R; ... Skorski, T; + view all (1999) Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. CANCER RES , 59 (12) 2815 - 2819.

Makris, A; Powles, TJ; Allred, DC; Ashley, SE; Trott, PA; Ormerod, MG; ... Dowsett, M; + view all (1999) Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study. Breast Cancer Research And Treatment , 53 51 - 59.

Mangham, DC; Isaacson, PG; (1999) A novel immunohistochemical detection system using mirror image complementary antibodies (MICA). Histopathology , 35 (2) 129 - 133.

Maxwell, P; Patterson, AH; Jamison, J; Miller, K; Rhodes, CA; Anderson, N; (1999) Alcohol-fixed cytospins protected by 10% polyethylene glycol for immunocytology external quality assurance. J PATHOL , 187 31A - 31A.

McCloskey, SC; Hinchliffe, SJ; Reid, ED; Lomas, DA; (1999) Familial risk of airflow obstruction and emphysema. THORAX , 54 A54 - A54.

McHugh, PJ; Gill, RD; Waters, R; Hartley, JA; (1999) Excision repair of nitrogen mustard-DNA adducts in Saccharomyces cerevisiae. NUCLEIC ACIDS RES , 27 (16) 3259 - 3266. Gold open access

McHugh, PJ; Hartley, JA; (1999) The induction and repair of DNA doublestrand breaks in nitrogen mustard treated Saccharomyces cerevisiae cells. BRIT J CANCER , 80 42 - 42.

McLean, M; Bisits, A; Davis, J; Walters, W; Hackshaw, A; de, VK; Smith, R; (1999) Predicting risk of preterm delivery by second trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein. American Journal of Obstetrics and Gynecology , 181 (1) 207 - 215.

Mengubas, K; Fahey, AA; Lewin, J; Mehta, AB; Hoffbrand, AV; Wickremasinghe, RG; (1999) Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation. EXP CELL RES , 249 (1) 116 - 122.

Mengubas, K; Riordan, FA; Bravery, CA; Lewin, J; Owens, DL; Mehta, AB; ... Wickremasinghe, RG; + view all (1999) Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism. ONCOGENE , 18 (15) 2499 - 2506.

Morgan, NV; Tipping, AJ; Joenje, H; Mathew, CG; (1999) High frequency of large intragenic deletions in the Fanconi anemia group A gene. AM J HUM GENET , 65 (5) 1330 - 1341.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (1999) Effect of adhesion molecule expression on survival of F-cells and F-reticulocytes in sickle cell disorders. BRIT J HAEMATOL , 105 72 - 72.

Mundee, Y; Porter, JB; (1999) Contribution of adhesion molecule expression and F(+)cell production to red cell survival in sickle cell disorders with and without hydroxyurea therapy. BLOOD , 94 (10) 421A - 421A.

Nacheva, EP; Sinclair, PB; Laversha, M; Telford, N; Chang, J; Ried, A; ... Green, AR; + view all (1999) Large deletions at the t(9;22) breakpoint are common and may identify a poor prognostic sub group of patients with chronic myeloid leukemia. BLOOD , 94 (10) 534A - 534A.

Nacheva, EP; Swanton, S; Hood, T; Grace, CD; Bench, A; Green, AR; (1999) Abnormalities of the long arm of chromosome 20 in myeloid malignancies. CYTOGENET CELL GENET , 85 (1-2) 15 - 15.

Nagral, A; Mehta, AB; Gomes, AT; Ellis, G; Jackson, BF; Sabin, CA; McIntyre, N; (1999) Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease. Clin Lab Haematol , 21 (2) 93 - 97.

Napier, MP; Hoare, D; Whelan, JS; (1999) Safe administration of high dose methotrexate in osteosarcoma: Carboxypeptidase G2 for idiosynchratic toxicity. British Journal of Cancer , 80 155 - 155.

Nathwani, AC; Persons, DA; Stevenson, SC; Frare, P; McClelland, A; Nienhuis, AW; Vanin, EF; (1999) Adenovirus-mediated expresssion of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector. Gene Ther , 6 (8) 1456 - 1468. 10.1038/sj.gt.3300974.

Neidle, S; Mann, J; Rayner, EL; Baron, A; Opoku-Boahen, Y; Simpson, IJ; ... Kelland, LR; + view all (1999) Symmetric bis-benzimidazoles: new sequence-selective DNA-binding molecules. CHEM COMMUN (10) 929 - 930.

Newell, DR; Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Dewsbury, P; ... Schultz, R; + view all (1999) Antiproliferative cyclin dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. CLIN CANCER RES , 5 3755S - 3755S.

Ng, T; (1999) Imaging Protein Kinase C Activation in Cells. Science , 283 (5410) 2085 - 2089. 10.1126/science.283.5410.2085.

Ng, TTC; Collins, IE; Kanner, SB; Humphries, MJ; Amft, N; Wickremasinghe, RG; ... Morrow, WJW; + view all (1999) Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus. LUPUS , 8 (1) 39 - 51.

Nieborowska-Skorska, M; Wasik, MA; Slupianek, A; Salomoni, P; Kitamura, T; Calabretta, B; Skorski, T; (1999) Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J EXP MED , 189 (8) 1229 - 1242.

Nitu, IC; Lee, CA; Dhillon, AP; Mistry, PK; (1999) Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses. CLIN LAB HAEMATOL , 21 (2) 139 - 141.

Noble, KE; Wickremasinghe, RG; DeCornet, C; Panayiotidis, P; Yong, KL; (1999) Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J IMMUNOL , 162 (3) 1376 - 1383.

Nutting, C; Brada, M; Brazil, L; Sibtain, A; Saran, F; Westbury, C; ... Ashley, S; + view all (1999) Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg , 90 (5) 823 - 827. 10.3171/jns.1999.90.5.0823.

Ojaimi, J; Masters, CL; McLean, C; Opeskin, K; McKelvie, P; Byrne, E; (1999) Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease. Annals of Neurology , 46 (4) 656 - 660.

Ojaimi, J; Masters, CL; Opeskin, K; McKelvie, P; Byrne, E; (1999) Mitochondrial respiratory chain activity in the human brain as a function of age. Mechanisms of Ageing and Development , 111 (1) 39 - 47.

Orchard, KH; Cooper, M; Mehta, A; Potter, M; Wijdenes, J; Borchardt, P; ... Prentice, HG; + view all (1999) Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies. BLOOD , 94 (10) 302B - 302B.

Pang, KF; Ganeshaguru, K; Hart, SM; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; (1999) Expression of the multidrug resistance protein gene homologues in B-CLL and AML cells. BLOOD , 94 (10) 280A - 280A.

Paramio, JM; Casanova, ML; Segrelles, C; Mittnacht, S; Lane, EB; Jorcano, JL; (1999) Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol , 19 (4) 3086 - 3094.

Pearce, D; Pizzey, A; Uhr, M; Gordon-Smith, EC; Pettengell, RCP; McGuckin, CP; (1999) Intracellular CD34 progenitor subset analysis. BRITISH JOURNAL OF HAEMATOLOGY , 105 57 - 57.

Pedley, RB; Sharma, SK; Boxer, GM; Boden, R; Stribbling, SM; Davies, L; ... Begent, RH; + view all (1999) Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. Cancer Res , 59 (16) 3998 - 4003.

Pedley, RB; Sharma, SK; Boxer, GM; Boden, R; Stribbling, SM; Davies, L; ... Begent, RHJ; + view all (1999) Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. CANCER RES , 59 (16) 3998 - 4003.

Perry, AR; Peniket, AJ; Watts, MJ; Leverett, D; Goldstone, AH; Linch, DC; (1999) Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis. BRIT J HAEMATOL , 105 (1) 280 - 287.

Peruzzi, F; Prisco, M; Dews, M; Salomoni, P; Grassilli, E; Romano, G; ... Baserga, R; + view all (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. MOL CELL BIOL , 19 (10) 7203 - 7215.

Platt, GM; Simpson, GR; Mittnacht, S; Schulz, TF; (1999) Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol , 73 (12) 9789 - 9795.

Plummer, R; Rees, C; Judson, I; Calvert, H; Highley, M; Trigo, J; ... Smith, M; + view all (1999) Phase I trial of ZD9331 in adult patients with refractory solid malignancies administered by 30-min infusion on days 1 and 8 with the cycle repeated every 3 weeks. EUR J CANCER , 35 S285 - S285.

Pollard, Y; Watts, MJ; Grant, D; Chavda, N; Linch, DC; Machin, SJ; (1999) Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. BRIT J HAEMATOL , 106 (2) 538 - 544.

Powell, MEB; Collingridge, DR; Saunders, MI; Hoskin, PJ; Hill, SA; Chaplin, DJ; (1999) Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. Radiotherapy and Oncology , 50 167 - 171.

Presneau, N; Laplace-Marieze, V; Sylvain, V; Lortholary, A; Hardouin, A; Bernard-Gallon, D; Bignon, YJ; (1999) Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast ovarian cancer families: possible implication of a mobile element. B CANCER , 86 (4) 385 - 390.

Rees, DC; Porter, JB; Clegg, JB; Weatherall, DJ; (1999) Why are hemoglobin F levels increased in HbE/beta thalassemia? BLOOD , 94 (9) 3199 - 3204.

Rege, KP; Bevan, DH; Chitolie, A; Shannon, MS; (1999) Risk factors and thrombosis after airline flight. THROMB HAEMOSTASIS , 81 (6) 995 - 996.

Roberts, I; Wienberg, J; Nacheva, E; Grace, C; Griffin, D; Coleman, N; (1999) Novel method for the production of multiple colour chromosome paints for use in karyotyping by fluorescence in situ hybridisation. Genes Chromosomes Cancer , 25 (3) 241 - 250.

Roberts, PJ; Mollapour, E; Watts, MJ; Linch, DC; (1999) Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: Selective regulation by stem cell factor involving the MAP kinase pathway. BLOOD , 94 (4) 1261 - 1272.

Robertson, J; Gale, RE; Linch, DC; Testa, NG; Chopra, R; (1999) Acquired skewed haemopoiesis in the elderly is independent of telomere shortening-implications for stem cell utilisation. BLOOD , 94 (10) 254A - 254A.

Robertson, JD; Gale, R; Wynn, RF; Robinson, SA; Greaves, MJ; Dougal, M; ... Chopra, R; + view all (1999) Telomere shortening in peripheral blood neutrophils and T cells with age in healthy individuals. BRIT J HAEMATOL , 105 103 - 103.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (1999) In vivo biotinylation studies: Specificity of labelling of reticulated platelets by thiazole orange and mepacrine. THROMB HAEMOSTASIS 826 - 826.

Sathar, MA; Soni, PN; Pegoraro, R; Simmonds, P; Smith, DB; Dhillon, AP; Dusheiko, GM; (1999) A new variant of GB virus C/hepatitis G virus (GBV-C/HGV) from South Africa. VIRUS RES , 64 (2) 151 - 160.

Saunders, M; Dische, S; Barrett, A; Harvey, A; Griffiths, G; Parmar, M; (1999) Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. Radiotherapy and Oncology , 52 (2) 137 - 148. 10.1016/S0167-8140(99)00087-0.

Saunders, MI; Dische, S; Rojas, A; (1999) CHART (continuous, hyperfractionated, accelerated radiotherapy): A tale of two disciplines. British Journal of Cancer , 80 (SUPPL. 1) 110 - 115. 10.1038/sj.bjc.6690329.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Noreen, H; Setterholm, M; (1999) HLA dictionary 1999: a summary of HLA-A, -B, -Cw, –DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Human Immunology , 60 1157 - 1181.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Noreen, H; Setterholm, M; (1999) The HLA dictionary 1999: a summary of HLA-A, -B, -C, –DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 54 (4) 409 - 437. 10.1034/j.1399-0039.1999.540412.x.

Shaw, BE; Potter, MN; Pawson, R; Virchis, AE; Patch, D; Murphy, K; ... Prentice, HG; + view all (1999) The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation. BLOOD , 94 (10) 608A - 608A.

Shoab, SS; Porter, J; Scurr, JH; Coleridge-Smith, PD; (1999) Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease - a prospective study. EUR J VASC ENDOVASC , 17 (4) 313 - 318.

Sirivatanauksorn, Y; Sirivatanauksorn, V; Bhattacharya, S; Davidson, BR; Dhillon, AP; Kakkar, AK; ... Lemoine, NR; + view all (1999) Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting. J PATHOL , 189 (3) 344 - 350.

Sirivatanauksorn, Y; Sirivatanauksorn, V; Bhattacharya, S; Davidson, BR; Dhillon, AP; Kakkar, AK; ... Lemoine, NR; + view all (1999) Genomic heterogeneity in synchronous hepatocellular carcinomas. GUT , 45 (5) 761 - 765.

Sirotnak, FM; Tolner, B; (1999) Carrier-mediated membrane transport of folates in mammalian cells. ANNU REV NUTR , 19 91 - 122.

Sivasothy, P; Dafforn, TR; Gettins, PGW; Lomas, DA; (1999) Pathogenic alpha(1)-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. THORAX , 54 A78 - A78.

Sivasothy, P; Dafforn, TR; Hiemstra, PS; Lomas, DA; (1999) The interaction of native, latent and cleaved plasma alpha-I-antitrypsin and human neutrophil defensin. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 159 (3) A481 - A481.

Sivasothy, P; Daffron, TR; Hiemstra, PS; Lomas, DA; (1999) The interaction of M, S, Z, latent and cleaved plasma alpha-1-antitrypsin with human neutrophil defensin-1. THORAX , 54 A81 - A81.

Smith, PG; Marshman, E; Calvert, AH; Newell, DR; Curtin, NJ; (1999) Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines. SEMINARS IN ONCOLOGY , 26 (2) 63 - 67.

Somervaille, TCP; Kirk, S; Dogan, A; Landon, GV; Mackinnon, S; (1999) Fulminant hepatic failure caused by adenovirus infection following bone marrow transplantation for Hodgkin's disease. BONE MARROW TRANSPL , 24 (1) 99 - 101.

Spanswick, VJ; Hartley, JM; Ward, TH; Hartley, JA; (1999) Measurement of drug-induced DNA interstrand crosslinking using the single-cell gel electrophoresis (comet) assay. Methods Mol Med , 28 143 - 154. 10.1385/1-59259-687-8:143.

Spencer, DIR; Robson, L; Bhatia, J; Sharma, SK; Michael, NP; Whitelegg, NR; ... Bergent, RHJ; + view all (1999) Identifying immunogenic sites on adept enzymes CPG2 using a SCFV phage library & SELDI (TM)-AMS. BRIT J CANCER , 80 52 - 52.

Srichairatanakool, S; Davis, BA; Porter, JB; (1999) Direct chelation of NTBI by desferrioxamine does not occur at clinically relevant rates in plasma. BRIT J HAEMATOL , 105 72 - 72.

Steingruber, HE; Dunham, A; Coffey, AJ; Clegg, SM; Howell, GR; Maslen, GL; ... Ross, MT; + view all (1999) High-resolution landmark framework for the sequence-ready mapping of Xq23-q26.1. GENOME RES , 9 (8) 751 - 762.

Stephens, R; Horton, R; Humphray, S; Rowen, L; Trowsdale, J; Beck, S; (1999) Gene organisation, sequence variation and isochore structure at the centromeric boundary of the human MHC. J MOL BIOL , 291 (4) 789 - 799.

Stephenson, JM; Griffioen, A; Woronowski, H; Phillips, AN; Petruckevitch, A; Keenlyside, R; ... MRC Collaborative Study HIV Infection Women,; + view all (1999) Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. SEX TRANSM INFECT , 75 (4) 247 - 252.

Sweetenham, JW; Carella, AM; Taghipour, G; Cunningham, D; Marcus, R; Della Volpe, A; ... European Grp Blood Marrow Transplantation,; + view all (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation. J CLIN ONCOL , 17 (10) 3101 - 3109.

Tamrakar, S; Mittnacht, S; Ludlow, JW; (1999) Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity. Oncogene , 18 (54) 7803 - 7809. 10.1038/sj.onc.1203211.

Theocharous, P; Lowdell, MW; Jones, AL; Prentice, HG; (1999) Ultrasensitive immunocytochemical and fluorescent detection and characterisation of circulating and micrometastatic tumour cells in patients with breast cancer. BRIT J HAEMATOL , 105 60 - 60.

Thorpe, KL; Schafer, AJ; Genin, E; Trowsdale, J; Beck, S; (1999) Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis. IMMUNOGENETICS , 49 (4) 256 - 265.

Thorpe, KL; Schafer, AJ; Genin, E; Trowsdale, J; Beck, S; (1999) Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis (vol 49, pg 256, 1999). IMMUNOGENETICS , 50 (1-2) 113 - 113.

Tolner, B; Singh, A; Esaki, T; Roy, K; Sirotnak, FM; (1999) Transcription of the mouse RFC-1 gene encoding a folate transporter. Multiplicity and properties of promoters with minimum requirements for their basal activity. GENE , 231 (1-2) 163 - 172.

Tonks, S; Marsh, SGE; Bunce, M; Bodmer, JG; (1999) Molecular typing for HLA Class I using ARMS-PCR: further developments following the 12th International Workshop. Tissue Antigens , 53 175 - 183.

Tsui, WMS; Colombari, R; Portmann, BC; Bonetti, F; Thung, SN; Ferrell, LD; ... Dhillon, AP; + view all (1999) Hepatic angiomyolipoma - A clinicopathologic study of 30 cases and delineation of unusual morphologic variants. AM J SURG PATHOL , 23 (1) 34 - 48.

Tsuzuki, S; Towatari, M; Saito, H; Enver, T; (1999) Potentiation of gata-factor activities through interactions with tee promyelocytic leukemia protein (PML) and the t(15;17) generated PML-RAR alpha oncoprotein. BLOOD , 94 (10) 258A - 259A.

Vanhaesebroeck, B; Higashi, K; Raven, C; Welham, M; Anderson, S; Brennan, P; ... Waterfield, MD; + view all (1999) Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J , 18 (5) 1292 - 1302. 10.1093/emboj/18.5.1292.

Vanhaesebroeck, B; Jones, GE; Allen, WE; Zicha, D; Hooshmand-Rad, R; Sawyer, C; ... Ridley, AJ; + view all (1999) Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol , 1 (1) 69 - 71. 10.1038/9045.

Vanhaesebroeck, B; Waterfield, MD; (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res , 253 (1) 239 - 254. 10.1006/excr.1999.4701.

Vevs, P; Davies, G; Webb, D; Jones, A; Hassan, A; Pagliuca, A; ... Mieli-Vergani, G; + view all (1999) Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing unrelated related donor BMT. BRIT J HAEMATOL , 105 66 - 66.

Veys, PA; Davies, EG; Webb, D; Jones, A; Hassan, A; Pagliuca, A; ... Mieli-Vergani, G; + view all (1999) Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing bone marrow transplantation. PEDIATR RES , 45 (5) 768 - 768.

Vig, S; Chitolie, A; Maurice, E; Boa, F; Bevan, DH; Halliday, A; ... Gordon-Smith, E; + view all (1999) Thromboelastography as a screen for hypercoagulable states predicts failure of peripheral arterial intervention. BLOOD , 94 (10) 114B - 114B.

Vincent-Lacaze, N; Snyder, RO; Gluzman, R; Bohl, D; Lagarde, C; Danos, O; (1999) Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol , 73 (3) 1949 - 1955.

Wald, NJ; Hackshaw, AK; Diamandis, EP; Melegos, DN; Int Prenatal Screening Res Grp,; (1999) Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. PRENATAL DIAG , 19 (7) 674 - 676.

Wald, NJ; Hackshaw, AK; Frost, CD; (1999) When can a risk factor be used as a worthwhile screening test? BRIT MED J , 319 (7224) 1562 - 1565.

Wald, NJ; Hackshaw, AK; Watt, H; (1999) Nuchal translucency and trisomy 18. PRENATAL DIAG , 19 (10) 995 - 996.

Wald, NJ; Watt, HC; Hackshaw, AK; (1999) Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. NEW ENGL J MED , 341 (7) 461 - 467.

Watts, MJ; Ings, SJ; Chavda, N; Mackinnon, S; Devereux, S; Linch, DC; (1999) Evaluation of clinical scale CD34+cell purification devices. BRIT J HAEMATOL , 105 58 - 58.

Watts, MJ; Ings, SJ; Flynn, M; Dodds, D; MacMillan, A; Goldstone, AH; Linch, DC; (1999) Remobilization of poor stem cell mobilizers is clinically worthwhile. BLOOD , 94 (10) 328A - 328A.

Webley, SD; Francis, R; Begent, RHJ; Hartley, JA; Hochhauser, D; (1999) Measurement of the critical DNA lesions produced by antibody directed enzyme prodrug therapy (ADEPT). BRIT J CANCER , 80 47 - 47.

West, MA; Antoniou, AN; Prescott, AR; Azuma, T; Kwiatkowski, DJ; Watts, C; (1999) Membrane ruffling, macropinocytosis and antigen presentation in the absence of gelsolin in murine dendritic cells. EUR J IMMUNOL , 29 (11) 3450 - 3455.

Westin, J; Lagging, LM; Wejstal, R; Norkrans, G; Dhillon, AP; (1999) Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. LIVER , 19 (3) 183 - 187.

Wheadon, H; Roberts, PJ; Watts, MJ; Linch, DC; (1999) Changes in signal transduction downstream from the granulocyte-macrophage colony-stimulating factor receptor during differentiation of primary hemopoietic cells. EXP HEMATOL , 27 (6) 1077 - 1086.

Whelan, J; Hoare, D; Leonard, P; (1999) Omeprazole does not alter plasma methotrexate clearance. Cancer Chemotherapy and Pharmacology , 44 (1) 88 - 89. 10.1007/s002800050949.

Wickramasinghe, SN; Thein, SL; Srichairatanakool, S; Porter, JB; (1999) Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I. BRIT J HAEMATOL , 107 (3) 522 - 525.

Wickremasinghe, RG; Ganeshaguru, K; Gordon, M; Parsons, A; Hoffbrand, AV; Prentice, HG; Mehta, AB; (1999) The protein tyrosine kinase inhibitor herbimycin A augments cytotoxic drug-induced apoptosis in B-CLL cells cultured with interleukln-4 or autologous plasma. BRIT J HAEMATOL , 105 86 - 86.

Wickremasinghe, RG; Hoffbrand, AV; (1999) Biochemical and genetic control of apoptosis: Relevance to normal hematopoiesis and hematological malignancies. BLOOD , 93 (11) 3587 - 3600.

Wickremasinghe, RG; Jones, DT; Gordon, M; Hoffbrand, AV; Prentice, HG; Mehta, AB; Ganeshaguru, K; (1999) Autologous plasma mediates survival of B-CLL cells via activation of the Akt protein kinase. BLOOD , 94 (10) 280A - 280A.

Wickremasinghe, RG; Jones, DT; Hoffbrand, AV; Prentice, HG; Mehta, AB; Ganeshaguru, K; (1999) Caspase 3 activation in the absence of cytoplasmic cytochrome C elevation during apoptotic death of B-CLL cells. BLOOD , 94 (10) 310A - 310A.

Wiener, E; Allen, D; Porter, RJ; Wickramasinghe, SN; Porter, JB; Chinprasertsuk, S; ... Wanachiwanawin, W; + view all (1999) Role of Fc gamma RI (CD64) in erythrocyte elimination and its up-regulation in thalassaemia. BRIT J HAEMATOL , 106 (4) 923 - 930.

Wijker, M; Morgan, NV; Herterich, S; van Berkel, CGM; Tipping, AJ; Gross, HJ; ... Mathew, CG; + view all (1999) Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. EUR J HUM GENET , 7 (1) 52 - 59.

Williams, GH; Stoeber, K; Mills, AD; Kubota, Y; Krude, T; Coleman, N; ... Laskey, RA; + view all (1999) The control of DNA replication in normal and neoplastic cells. J PATHOL , 187 43A - 43A.

Williamson, LM; Lowe, S; Love, EM; Cohen, H; Soldan, K; McClelland, DBL; ... Barbara, JAJ; + view all (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BRIT MED J , 319 (7201) 16 - 19.

Williamson, LM; Lowe, S; Love, EM; Cohen, H; Soldan, K; McClelland, DBL; ... Barbara, JAJ; + view all (1999) Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. British Medical Journal , 318 (7201) 16 - 19.

Wilson, SC; Howard, PW; Forrow, SM; Hartley, JA; Adams, LJ; Jenkins, TC; ... Thurston, DE; + view all (1999) Design, synthesis, and evaluation of a novel sequence-selective epoxide-containing DNA cross-linking agent based on the pyrrolo[2,1-c][1,4]benzodiazepine system. J MED CHEM , 42 (20) 4028 - 4041.

Wittke, B; Mackie, IJ; Machin, SJ; Timm, U; Zell, M; Goggin, T; (1999) Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers. BRIT J CLIN PHARMACO , 47 (5) 521 - 530.

Woll, P; Judson, I; Lee, SM; Rodenhuis, S; Nielsen, OS; Buesa, JM; ... Verweij, J; + view all (1999) Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma group. European Journal of Cancer , 35 (3) 410 - 412.

Woll, PJ; Carmichael, J; Chan, S; Howell, A; Ranson, M; Miles, D; ... Welbank, H; + view all (1999) Phase II study results on safety and efficacy of CAELYX (R) (DOXIL (R)) in combination with paclitaxel in the treatment of metastatic breast cancer. EUR J CANCER , 35 S322 - S322.

Wong, KCK; Meyer, T; Harding, DI; Dick, JRT; Vrbova, G; Greensmith, L; (1999) Integrins at the neuromuscular junction are important for motoneuron survival. EUR J NEUROSCI , 11 (9) 3287 - 3292.

Yaguchi, H; Yoshida, M; Ejima, Y; Miyakoshi, J; (1999) Effect of high-density extremely low frequency magnetic field on sister chromatid exchanges in mouse m5S cells. Mutat Res , 440 (2) 189 - 194.

Yong, K; Fahey, A; Reeve, L; Nicholls, C; Thomas, NSB; Pizzey, A; ... Linch, DC; + view all (1999) Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF-1 and MIP-3 beta compared with mobilized adult progenitor cells. BRIT J HAEMATOL , 107 (2) 441 - 449.

Yong, K; Fahey, A; Thomas, NSB; Inge, S; Watts, M; Linch, DC; (1999) Transendothelial migration of CD34(+) cells requires growth factor activation and occurs predominantly in G(0)/G(1) phase of the cell cycle. BLOOD , 94 (10) 40A - 40A.

Yousaf, N; Williams, BD; (1999) Monoclonal IgG antibodies influence the migration patterns of lymphocytes in vivo. Int Arch Allergy Immunol , 118 (1) 59 - 66.

Book chapter

Kocjan, GK; (1999) Cytology of the sentinel node. In: Keshtgar, MRS and Waddington, W and Lakhani, SR, (eds.) The Sentinel Node in Surgical Oncology. (113 - 118). Springer-Verlag: Berlin, Heidelberg, New York.

Conference item

Allford, SL; Harrison, P; Mackie, IJ; Cohen, H; Machin, SJ; (1999) Platelet activation markers in thrombotic thrombocytopenic purpura. Presented at: UNSPECIFIED.

Proceedings paper

Allford, SL; Harrison, P; Cohen, H; Mackie, IJ; Machin, SJ; (1999) Platelet activation in thrombotic thrombocytopenic purpura. In: THROMB HAEMOSTASIS. (pp. 361 - 361). F K SCHATTAUER VERLAG GMBH

Arnold, J; Holmes, Z; Pickering, W; Regan, L; Cohen, H; (1999) Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage. In: THROMB HAEMOSTASIS. (pp. 535 - 536). F K SCHATTAUER VERLAG GMBH

Arnold, J; Holmes, Z; Pickering, W; Regan, L; Cohen, H; (1999) Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage. In: BRIT J HAEMATOL. (pp. 45 - 45). BLACKWELL SCIENCE LTD

Begent, RHJ; (1999) Targeting cancer therapy. In: BRITISH JOURNAL OF CANCER. (pp. 104 - 109). CHURCHILL LIVINGSTONE

Cassoni, AM; Whelan, JS; (1999) Ewing's sarcoma: hyperfractionated radiotherapy with concurrent chemotherapy: acute toxicity. A prospective single institutional study. In: Sarcoma. (pp. 45 - 45).

Emery, VC; (1999) Viral dynamics during active cytomegalovirus infection and pathology. In: INTERVIROLOGY. (pp. 405 - 411). KARGER

Frohlich, B; Paulussen, M; Craft, A; Judson, I; Ladenstein, R; Oberlin, O; ... Jurgens, HFEICESS92UE-E99; + view all (1999) Therapiekonzepte bei non-responden/rezidivpatienten mit Eing Sarkomen im kindesalter. In: Annual Meeting of German and Austrian Socities of Haematology and Oncology, October 3-6th 1999. Onkologie Supp II vol 22.

Gan, TJ; Bennett-Guerrero, E; Phillips-Bute, B; Wakeling, H; Moskowitz, DM; Olufolabi, Y; ... Hextend Study Grp,; + view all (1999) Hextend (R), a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial. In: ANESTHESIA AND ANALGESIA. (pp. 992 - 998). LIPPINCOTT WILLIAMS & WILKINS

Gribble, SM; Sinclair, PB; Grace, C; Green, AR; Nacheva, EP; (1999) Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis. In: CANCER GENET CYTOGEN. (pp. 7 - 17). ELSEVIER SCIENCE INC

Holmes, Z; Backos, M; Atoyebi, W; Pickering, W; Regan, L; Cohen, H; (1999) Screening for heritable thrombophilic risk factors in a recurrent miscarriage population. In: THROMB HAEMOSTASIS. (pp. 534 - 535). F K SCHATTAUER VERLAG GMBH

Holmes, Z; Backos, M; Atoyebi, W; Pickering, W; Regan, L; Cohen, H; (1999) Screening for heritable thrombophilic risk factors in a recurrent miscarriage population. In: BRIT J HAEMATOL. (pp. 45 - 45). BLACKWELL SCIENCE LTD

Kottaridis, PD; Peggs, K; Harrison, C; Angus, G; Peniket, A; Miller, B; ... Goldstone, AH; + view all (1999) Age over 60 is not a barrier for successful autologous stem cell transplantation in selected patients with lymphoma: A single institution's experience in 37 consecutive patients. In: BLOOD. (pp. 170A - 170A). AMER SOC HEMATOLOGY

Ledermann, JA; Herd, R; Maraninchi, D; Viens, P; Buclon, M; Chauvin, F; ... Rosti, G; + view all (1999) UNSPECIFIED In: (Proceedings) High Dose Chemotherapy in Ovarian Cancer:An Analysis of the Experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 Years. (pp. 360a - ?).

Napier, NP; Hoare, D; Whelan, JS; (1999) Safe administration of high dose methotrexate in osteosarcoma: carboxypeptidase G2 for idiosyncratic toxicity. In: British Cancer Research Meeting 1999, Edinburgh.

Peggs, KS; Kottaridis, PD; Preiser, W; McCaig, N; Brink, N; Ward, K; ... Mackinnon, S; + view all (1999) Molecular monitoring for CMV infection after allogeneic transplantation: Benefits and limitations of PCR directed pre-emptive antiviral therapy. In: BLOOD. (pp. 337A - 337A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Ainsworth, J; Pizzey, A; Moss, PAH; Mackinnon, S; (1999) CMV specific HLA-tetramer sorting of ex-vivo expanded CD8+CTL: Selection of highly restricted clonal populations suitable for adoptive cellular therapy. In: BLOOD. (pp. 395A - 395A). AMER SOC HEMATOLOGY

Strauss, S; McTiernan, A; Whelan, JS; (1999) Recurrence of osteosarcoma after disease-free intervals exceeding 5 years. In: British Orthopaedic Oncology Society, March 1999.

Verfuerth, S; Peggs, K; Mackinnon, S; (1999) Generation of CMV-specific T cells for adoptive immunotherapy after allogeneic BMT: A novel in vitro culture assay that is free of live virus which uses donor dendritic cells pulsed with CMV antigen. In: BLOOD. (pp. 155A - 155A). AMER SOC HEMATOLOGY

Verfuerth, S; Peggs, KS; Vyas, P; Barnett, L; O'Reilly, RJ; Mackinnon, S; (1999) Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping following T cell depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T cell repertoire. In: BLOOD. (pp. 344A - 345A). AMER SOC HEMATOLOGY

Whelan, JS; Goodchild, K; Strauss, S; McTiernan, A; Driver, D; Kilby, AM; Cassoni, AM; (1999) Intensive induction therapy (VIDE) including stem cell collection for Ewing's family of tumours. In: British Cancer Research Meeting 1999, Edinburgh.

Yung, L; Kottaridis, PD; Peggs, K; Miller, B; McKeag, N; Devereux, S; ... Mackinnon, S; + view all (1999) Older age is not a barrier to successful allogeneic BMT. In: BONE MARROW TRANSPL. (pp. S235 - S235). STOCKTON PRESS

This list was generated on Sun Apr 19 10:16:52 2015 BST.